← Leaderboards
Andrew E Sloan
H. Lee Moffitt Cancer Ctr & Res Inst
$2,473,072
Attributed
$5,675,033
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2006–22$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,675,033 · 4
By mechanism
R01$3,405,502 · 1
U01$1,453,798 · 1
R21$409,455 · 1
K08$406,278 · 1
Top collaborators
- Susann M Brady-Kalnay5 shared
- Edward Gastineau5 shared
- Stanton L Gerson3 shared
- Thomas S Mccormick2 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseTumorMalignant NeoplasmsTumor MicroenvironmentGlioblastomaIn VivoClinical TrialsChemoradiationMalignant Neoplasm Of BrainBrain NeoplasmsLaboratoriesSafetyDoseToxic EffectCollaborationsBrainRecurrenceSensitivity And SpecificityImageOperative Surgical ProceduresNeoplastic CellImaging StudyPerformanceFda Approved
Grant awards (13)
Differential Diagnosis of recurrent GBM versus Radiation Necrosis using MDSCbiomarkers$221,286
R21 · FY2022 · CA · contact PI
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors$713,380
R01 · FY2021 · CA
Chemoprotection & Immune Remodeling after Hematopoietic Progenitor Cell Gene Therapy for Glioblastoma$433,323
U01 · FY2021 · CA · contact PI
Differential Diagnosis of recurrent GBM versus Radiation Necrosis using MDSCbiomarkers$188,169
R21 · FY2021 · CA · contact PI
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors$682,371
R01 · FY2020 · CA
Chemoprotection & Immune Remodeling after Hematopoietic Progenitor Cell Gene Therapy for Glioblastoma$455,284
U01 · FY2020 · CA · contact PI
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors$658,439
R01 · FY2019 · CA
Chemoprotection & Immune Remodeling after Hematopoietic Progenitor Cell Gene Therapy for Glioblastoma$565,191
U01 · FY2019 · CA · contact PI
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors$688,403
R01 · FY2018 · CA
A Novel Molecular Imaging Agent for Surgical Resection of Invasive Brain Tumors$662,909
R01 · FY2017 · CA
Chemokine Secreting Dendritic Cells for Glioma Immunotherapy$135,426
K08 · FY2008 · CA · contact PI
Chemokine Secreting Dendritic Cells for Glioma Immunotherapy$135,426
K08 · FY2007 · CA · contact PI
Chemokine Secreting Dendritic Cells for Glioma Immunotherapy$135,426
K08 · FY2006 · CA · contact PI